Summit, NJ, United States of America

Whitney Lane Petrilli

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Elexopharm Gmbh. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Whitney Lane Petrilli. Retrieved from https://idiyas.com/inventor/whitney-lane-petrilli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 12.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Jersey City, NJ (US) (2015)
  • Summit, NJ (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Path of Whitney Lane Petrilli

Introduction

Whitney Lane Petrilli is a prominent inventor hailing from Summit, NJ, USA. With a remarkable portfolio of two patents, she has made significant contributions to the fields of pharmacology and biochemistry. Her latest inventions focus on groundbreaking treatments for cardiovascular and metabolic conditions, showcasing her commitment to enhancing human health through innovation.

Latest Patents

Petrilli's latest patents highlight her expertise in developing novel compounds. The first patent, titled "Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders," presents allosteric binding compounds aimed at inducing PCSK9 protein degradation. This innovation has potential therapeutic applications for treating conditions such as atherosclerosis, hypercholesterolemia, and other cardiovascular diseases. It also includes methods for the detection and quantification of PCSK9 in biological samples.

Her second patent, "Aldosterone synthase inhibitors," details a series of tricyclic triazole analogs that selectively inhibit aldosterone synthetase. This patent not only encompasses the compounds themselves but also pharmaceutical compositions formulated from these compounds. Petrilli's work in this area opens avenues for the treatment and prevention of medical conditions linked to aldosterone synthetase inhibition.

Career Highlights

Petrilli has garnered valuable experience by working with esteemed organizations such as Merck Sharp & Dohme Corporation and Elexopharm GmbH. Her contributions in these companies have allowed her to refine her skills in research and development, leading to her successful patent applications.

Collaborations

Throughout her career, Petrilli has collaborated with notable individuals like Yusheng Xiong and Jerry Andrew Taylor. These partnerships have facilitated a synergistic approach to innovation, combining diverse expertise to drive advancements in their fields.

Conclusion

Whitney Lane Petrilli represents the spirit of innovation with her valuable patents and contributions to the medical field. Her research focuses on critical health challenges, showcasing her dedication to improving patient outcomes through the development of novel therapeutics. As she continues to explore new frontiers in pharmacology, her work is a testament to the impact that dedicated inventors can have on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…